This padding only appears when menu bar covers the content below (browser width 1199px)

We use a C. elegans-based, new alternative method (NAM) to test chemicals for systemic toxicity, developmental and reproductive toxicity, and developmental neurotoxicity. Our innovative high-throughput platform integrated with AI-enabled data analytics provides cost effective and rapid testing.
Protect public health with early identification of toxic chemicals
Help industries reduce animal use and meet regulatory compliance
Evaluate industrial chemicals that require further in vivo testing



Protect public health with early identification of toxic chemicals
Help industries reduce animal use and meet regulatory compliance
Evaluate industrial chemicals that require further in vivo testing
Welcome to the vivoVerse
To reflect our growing portfolio of products and services, Newormics LLC has rebranded to become vivoVerse Inc.
Latest News
vivoVerse awarded SBIR Phase II grant from NIEHS
vivoVerse is excited to announce it has been awarded a $1.83M Phase II SBIR grant from the National Institute of Environmental Health Sciences (NIEHS) for the continued development of the company’s in vivo imaging and screening technologies.
vivoVerse cofounders publish single-cell isolation method using femtosecond laser microdissection (fs-LM)
vvivoVerse cofounders Dr. Adela Ben-Yakar and Dr. Sudip Mondal have published an article in Nature Methods titled “Femtosecond laser microdissection for isolation of regenerating C. elegans neurons for single-cell RNA sequencing.” This publication...
More news...